Evaluation of Risk Factors for Malignancy Obtained by Means of Fine Needle Aspiration Biopsies in Thyroid Nodules and Surgical Outcomes of Patients with Bethesda Category III (AUS/FLUS)

被引:1
|
作者
Kimiloglu, Elife [1 ]
Ozdemir, Muhammed [2 ]
Cobanoglu, Pelin [1 ]
Kavuncu, Beyza [3 ]
Gonullu, Dogan [4 ]
机构
[1] Hlth Univ, Gaziosmanpasa Training & Res Hosp, Dept Pathol, Istanbul, Turkiye
[2] Siverek State Hosp, Minist Hlth, Siverek, Sanliurfa, Turkiye
[3] Mediwell Clin, 1A Lawsdone Rd, London N17 OLL, England
[4] Kafkas Univ, Sch Med, Dept Gen Surg, Kars, Turkiye
关键词
atypia of undetermined significance; fine needle biopsy; nuclear atypia; microfollicular atypia; TIRADS; UNDETERMINED SIGNIFICANCE; ATYPIA/FOLLICULAR LESION; ASSOCIATION GUIDELINES; FOLLICULAR LESION; ATYPIA; MANAGEMENT; SYSTEM; CARCINOMA; CYTOLOGY;
D O I
10.21614/chirurgia.2812
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The nodules diagnosed as the "atypia of undetermined significance" category are a heterogenous group with an indeterminate risk of malignancy. This study aimed to perform a detailed cytological examination of the preparations to determine the cytomorphological criteria that may be useful to distinguish benign cases from malignant ones, correlate them with ultrasonographic findings, and compare them with the final pathological result in surgically treated patients. Methods: The preparations of patients classified as Bethesda 3 were re-evaluated; presence or absence of one of 11 parameters (hypochromasia, oval nucleus, colloid, intra-nuclear pseudoinclusions, nuclear grooving, nuclear moldering, isolated nuclear enlargement, nuclear irregularity, nuclear size, microfollicular pattern, distinct nucleoli) and correlating with surgical outcomes by adding ultrasonographic findings to statistically significant parameters. Results: Two hundred and six fine needle aspirations (FNA) procedures were classified as Bethesda 3. A total of 53 patients underwent surgery; 28 (52.8%) of them were benign, and 25 (47.1%) were malignant. Thirty-two (15.5%) accepted direct surgery; 53 patients underwent repeat FNA at 3-6 month intervals and those with malignancy and repeated Bethesda 3 interpretation were operated. One hundred twenty-one (69.5%) patients who did not undergo biopsy were invited for ultrasonographic controls at 3-6 month intervals. Among the 11 cytomorphologic parameters evaluated, 7 were found to be statistically significant (p<0.05) with malignancy. When at least 3 of these parameters were positive, the malignancy rate was 92%. Malignancy was present in 19 (61.3%) of the patients with high risk nodules (TIRADS >= 4), compared to only 6 (35.8%) of the low-risk (TIRADS <= 3); there was a significant correlation between the presence of malignancy and TIRADS score (p=0.015). The preparations that displayed nucleus atypia were closely associated with the ultrasonographically high-risk group. Conclusion: The parameters indicating nuclear atypia, presence of more than 3 cytomorphological factors, TIRADS score >= 4 were significantly associated with malignancy; nuclear atypia were closely associated with the ultrasonographically high TIRADS. No significant correlation was found between the presence of "microfollicular pattern" and malignancy.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 25 条
  • [1] Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)
    Ho, Allen S.
    Sarti, Evan E.
    Jain, Kunal S.
    Wang, Hangjun
    Nixon, Iain J.
    Shaha, Ashok R.
    Shah, Jatin P.
    Kraus, Dennis H.
    Ghossein, Ronald
    Fish, Stephanie A.
    Wong, Richard J.
    Lin, Oscar
    Morris, Luc G. T.
    THYROID, 2014, 24 (05) : 832 - 839
  • [2] Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS)
    Kuru, B.
    Atmaca, A.
    Tarim, I. A.
    Kefeli, M.
    Topgul, K.
    Yoruker, S.
    Elmali, M.
    Danaci, M.
    EJSO, 2016, 42 (01): : 87 - 93
  • [3] Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy
    Kuru, Bekir
    Atmaca, Aysegul
    Kefeli, Mehmet
    DIAGNOSTIC CYTOPATHOLOGY, 2016, 44 (05) : 394 - 398
  • [4] Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy
    Ng, Jennifer Lourdes
    Escueta, Luz Margaret
    Dampil, Oliver Allan
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (02): : 86 - 93
  • [5] Malignancy outcomes and the impact of repeat fine needle aspiration of thyroid nodules with Bethesda category III cytology: A multicenter experience
    Koseoglu, Derya
    Ozdemir Baser, Ozden
    Cetin, Zeynep
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (10) : 1110 - 1115
  • [6] The Prediction of Malignancy Risk in Thyroid Nodules Classified as Bethesda System Category III (AUS/FLUS) and the Role of Ultrasound Finding for Prediction of Malignancy Risk
    Alshahrani, Awad S.
    Alamri, Abdulrahman S.
    Balkhoyor, Abdulrahman H.
    Mahzari, Moeber M.
    Alshieban, Saeed S.
    Majed, Pharaon M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [7] Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology
    Bayrak, Busra Yaprak
    Eruyar, Ahmet Tugrul
    BMC ENDOCRINE DISORDERS, 2020, 20 (01)
  • [8] WHICH FACTORS ARE ASSOCIATED WITH MALIGNANCY IN THYROID NODULES CLASSIFIED AS BETHESDA CATEGORY 3 (AUS/FLUS) AND HOW DO THEY INFLUENCE THE PATIENT'S MANAGEMENT?
    Kaya, C.
    Bozkurt, E.
    Mut, D. Turkyilmaz
    Mihmanli, M.
    Uludag, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2019, 15 (04) : 491 - 496
  • [9] Thyroid cancer detection rate and associated risk factors in patients with thyroid nodules classified as Bethesda category III
    Mileva, Magdalena
    Stoilovska, Bojana
    Jovanovska, Anamarija
    Ugrinska, Ana
    Petrushevska, Gordana
    Kostadinova-Kunovska, Slavica
    Miladinova, Daniela
    Majstorov, Venjamin
    RADIOLOGY AND ONCOLOGY, 2018, 52 (04) : 370 - 376
  • [10] Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III
    Huang, Jianhao
    Shi, Hongyan
    Song, Muye
    Liang, Jinan
    Zhang, Zhiyuan
    Chen, Xiaohang
    Liu, Yongchen
    Wang, Sanming
    Wu, Zeyu
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12